loadpatents
name:-0.18200206756592
name:-0.045619964599609
name:-0.019870042800903
MINGOZZI; FEDERICO Patent Filings

MINGOZZI; FEDERICO

Patent Applications and Registrations

Patent applications and USPTO patent grants for MINGOZZI; FEDERICO.The latest application filed is for "acid-alpha glucosidase variants and uses thereof".

Company Profile
12.13.28
  • MINGOZZI; FEDERICO - PHILADELPHIA PA
  • Mingozzi; Federico - Paris FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Acid-alpha Glucosidase Variants And Uses Thereof
App 20220275396 - MINGOZZI; FEDERICO ;   et al.
2022-09-01
Method for reducing the expression of NKCC1 in a subject
Grant 11,427,836 - Mingozzi , et al. August 30, 2
2022-08-30
Acid-alpha glucosidase variants and uses thereof
Grant 11,421,211 - Mingozzi , et al. August 23, 2
2022-08-23
AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies
Grant 11,408,899 - High , et al. August 9, 2
2022-08-09
Peptide-Modified Hybrid Recombinant Adeno-Associated Virus Serotype Between AAV9 and AAVrh74 with Reduced Liver Tropism and Increased Muscle Transduction
App 20220228167 - RONZITTI; Giuseppe ;   et al.
2022-07-21
INDUCING IMMUNE TOLERANCE BY rAAV VECTORS
App 20220213505 - MINGOZZI; Federico ;   et al.
2022-07-07
Method for removing anti-AAV antibodies from a blood-derived composition
Grant 11,376,321 - Bertin , et al. July 5, 2
2022-07-05
Hybrid Promoters For Muscle Expression
App 20220162640 - RONZITTI; GIUSEPPE ;   et al.
2022-05-26
Acid-alpha glucosidase variants and uses thereof
Grant 11,339,406 - Mingozzi , et al. May 24, 2
2022-05-24
Composition and methods for highly efficient gene transfer using AAV capsid variants
Grant 11,279,950 - Yazicioglu , et al. March 22, 2
2022-03-22
In Vitro Assay For Detecting Enhancers And Inhibitors Of Adeno Associated Virus (aav) Vector Transduction And/or Detecting Or Quantitating Anti-aav Binding Antibodies
App 20220011308 - KURANDA; Klaudia ;   et al.
2022-01-13
Hybrid Regulatory Elements
App 20210346519 - MINGOZZI; FEDERICO ;   et al.
2021-11-11
Mini-gde For The Treatment Of Glycogen Storage Disease Iii
App 20210292724 - RONZITTI; GIUSEPPE ;   et al.
2021-09-23
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
App 20210246469 - LACROIX-DESMAZES; Sebastien ;   et al.
2021-08-12
Compositions And Methods For Increasing Or Enhancing Transduction Of Gene Therapy Vectors And For Removing Or Reducing Immunoglobulins
App 20210228738 - LACROIX-DESMAZES; Sebastien ;   et al.
2021-07-29
Method For Reducing The Expression Of Nkcc1 In A Subject
App 20210130847 - Mingozzi; Federico ;   et al.
2021-05-06
Acid-alpha Glucosidase Variants And Uses Thereof
App 20210040503 - MINGOZZI; FEDERICO ;   et al.
2021-02-11
Treatment Of Glycogen Storage Disease Iii
App 20200289673 - MINGOZZI; FEDERICO ;   et al.
2020-09-17
Virus vectors for highly efficient transgene delivery
Grant 10,640,785 - Mingozzi , et al.
2020-05-05
Method For Removing Anti-aav Antibodies From A Blood-derived Composition
App 20200069790 - BERTIN; BERANGERE ;   et al.
2020-03-05
Acid-alpha Glucosidase Variants And Uses Thereof
App 20190390224 - MINGOZZI; FEDERICO ;   et al.
2019-12-26
Acid-alpha Glucosidase Variants And Uses Thereof
App 20190390184 - MINGOZZI; FEDERICO ;   et al.
2019-12-26
Acid-alpha Glucosidase Variants And Uses Thereof
App 20190390225 - MINGOZZI; FEDERICO ;   et al.
2019-12-26
Treatment Of Hyperbilirubinemia
App 20190374619 - MINGOZZI; FEDERICO ;   et al.
2019-12-12
Treatment of hyperbilirubinemia
Grant 10,471,132 - Mingozzi , et al. Nov
2019-11-12
AAV8 vector with enhanced functional activity and methods of use thereof
Grant 10,392,632 - Wright , et al. A
2019-08-27
Compositions And Methods For Detection And Modulation Of T Cell Mediated Immune Responses Against Viral Vectors Utilized For Gene Therapy
App 20190083658 - High; Katherine A. ;   et al.
2019-03-21
Composition And Methods For Highly Efficient Gene Transfer Using Aav Capsid Variants
App 20180245098 - Yazicioglu; Mustafa N. ;   et al.
2018-08-30
Composition and methods for highly efficient gene transfer using AAV capsid variants
Grant 9,909,142 - Yazicioglu , et al. March 6, 2
2018-03-06
Treatment Of Hyperbilirubinemia
App 20170028036 - MINGOZZI; FEDERICO ;   et al.
2017-02-02
Aav Vector And Assay For Anti-aav (adeno-associated Virus) Neutralizing Antibodies
App 20160123990 - HIGH; Katherine A. ;   et al.
2016-05-05
Compositions And Methods For Detection And Modulation Of T Cell Mediated Immune Responses Against Viral Vectors Utilized For Gene Therapy
App 20150320886 - High; Katherine A. ;   et al.
2015-11-12
Compositions and methods for detection and modulation of T cell mediated immune responses against viral vectors utilized for gene therapy
Grant 9,075,044 - High , et al. July 7, 2
2015-07-07
Aav Vector Compositions And Methods For Gene Transfer To Cells, Organs And Tissues
App 20150111955 - High; Katherine A. ;   et al.
2015-04-23
Composition And Methods For Highly Efficient Gene Transfer Using Aav Capsid Variants
App 20150065562 - Yazicioglu; Mustafa N. ;   et al.
2015-03-05
Virus Vectors For Highly Efficient Transgene Delivery
App 20140336245 - Mingozzi; Federico ;   et al.
2014-11-13
AAV8 Vector with Enhanced Functional Activity and Methods of Use Thereof
App 20140037585 - Wright; John Fraser ;   et al.
2014-02-06
Compositions and Methods for Detection and Modulation of T Cell Mediated Immune Responses Against Viral Vectors Utilized for Gene Therapy
App 20100035806 - High; Katherine A. ;   et al.
2010-02-11
Company Registrations
SEC0001732126Mingozzi Federico

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed